CAM
BMY icon

ClariVest Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

ClariVest Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80
Closed -$4.32K – 860
2024
Q1 		$4.32K Buy
80
+35
+78% +$1.78K ﹤0.01% 490
2023
Q4 		$2.31K Sell
45
-224,842
-100% -$11.8M ﹤0.01% 531
2023
Q3 		$13.1M Sell
224,887
-15,661
-7% -$960K 0.71% 31
2023
Q2 		$15.4M Sell
240,548
-44,700
-16% -$3M 0.77% 27
2023
Q1 		$19.8M Sell
285,248
-12,607
-4% -$889K 0.88% 20
2022
Q4 		$21.4M Sell
297,855
-7,956
-3% -$600K 1.03% 20
2022
Q3 		$21.7M Sell
305,811
-18,200
-6% -$1.32M 1.05% 17
2022
Q2 		$24.9M Sell
324,011
-14,400
-4% -$1.1M 1.09% 15
2022
Q1 		$24.7M Buy
338,411
+13,185
+4% +$885K 0.97% 23
2021
Q4 		$20.3M Sell
325,226
-8,622
-3% -$506K 0.62% 32
2021
Q3 		$19.8M Sell
333,848
-9,156
-3% -$603K 0.64% 33
2021
Q2 		$22.9M Sell
343,004
-17,500
-5% -$1.14M 0.76% 25
2021
Q1 		$22.8M Sell
360,504
-38,546
-10% -$2.4M 0.8% 29
2020
Q4 		$24.8M Sell
399,050
-62,907
-14% -$3.87M 0.84% 25
2020
Q3 		$27.9M Sell
461,957
-138,933
-23% -$8.36M 0.91% 22
2020
Q2 		$35.3M Sell
600,890
-122,832
-17% -$7.35M 0.96% 23
2020
Q1 		$40.3M Buy
723,722
+295,243
+69% +$18M 1.21% 21
2019
Q4 		$27.5M Buy
+428,479
New +$24.5M 0.63% 38

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClariVest Asset Management's BMY Position: Q2 2024 in Review

ClariVest Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 80 shares — an estimated $4.32K sold.

ClariVest Asset Management first reported a position in BMY in Q4 2019 and held it in 18 quarters. The position peaked at $40.3M in Q1 2020. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • ClariVest Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • ClariVest Asset Management sold 80 Bristol-Myers Squibb shares in Q2 2024, an estimated $4.32K.
  • ClariVest Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 18 quarters.
  • ClariVest Asset Management's Bristol-Myers Squibb position peaked at $40.3M in Q1 2020.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.